The problem arises when systems blur distinctions in ways that confuse patients and strain teams. The real fault line in ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

Medicaid programs made more than $200 million in improper payments to healthcare providers between 2021 and 2022 for people ...

Arizona/Utah: The large outbreak on the Arizona-Utah border continues to grow, with 190 cases in Arizona (14 new cases) and ...

Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...

Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic ...

At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether ...

The FDA has expanded the indication of ferric maltol (Accrufer) capsules for the treatment of iron deficiency to include ...

FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...

Science Signaling retracted a 2017 paper that linked a specific amyloid form (amyloid-beta 56) to tau pathology after an ...

Starting an incretin receptor agonist -- especially tirzepatide (Mounjaro, Zepbound) -- was associated with reduced risks of ...